Lista de obras - Kathryn Pritchard-Jones - Dominio Público Uruguay

A genome-wide association study identifies susceptibility loci for Wilms tumor

scientific journal article

A prospective study of admissions for febrile neutropenia in secondary paediatric units in South East England.

artículo científico publicado en 2007

Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma

article

An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity

scientific article published on 11 March 2020

Analysis by array CGH of genomic changes associated with the progression or relapse of Wilms' tumour

artículo científico publicado en 2007

Array CGH profiling of favourable histology Wilms tumours reveals novel gains and losses associated with relapse

artículo científico publicado en 2006

Cancer in children and adolescents in Europe: developments over 20 years and future challenges.

artículo científico publicado en 2006

Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis

artículo científico publicado el 1 de diciembre de 1991

Centralising specialist cancer surgery services in England: survey of factors that matter to patients and carers and health professionals.

artículo científico publicado en 2018

Childhood cancer incidence and survival in Japan and England: A population-based study (1993-2010).

artículo científico publicado en 2017

Children with cancer: driving the global agenda ⬇️

artículo científico publicado el 20 de febrero de 2013

Commissioning: aiming for a gold standard of care

artículo científico publicado en 2013

Comparative genomic hybridization and BUB1B mutation analyses in childhood cancers associated with mosaic variegated aneuploidy syndrome

article

Complex patterns of chromosome 9 alterations including the p16INK4a locus in Wilms tumours

artículo científico publicado en 2007

Confirmation of FWT1 as a Wilms' tumour susceptibility gene and phenotypic characteristics of Wilms' tumour attributable to FWT1

artículo científico publicado en 1998

Congenital mesoblastic nephroma 50 years after its recognition: A narrative review

artículo científico publicado en 2017

Consent to tissue banking for research: qualitative study and recommendations ⬇️

artículo científico publicado el 18 de mayo de 2012

Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumor.

artículo científico publicado en 2008

Constitutional translocation breakpoint mapping by genome-wide paired-end sequencing identifies HACE1 as a putative Wilms tumour susceptibility gene

artículo científico publicado en 2009

DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome

artículo científico publicado en 2011

Delineation of a 1Mb breakpoint region at 1p13 in Wilms tumors by fine-tiling oligonucleotide array CGH

scientific article published on 01 June 2007

Differential splicing of exon 5 of the Wilms tumour (WT1) gene ⬇️

artículo científico publicado el 1 de agosto de 1997

Discrete-choice experiment to analyse preferences for centralizing specialist cancer surgery services.

artículo científico publicado en 2018

Dose finding study of oral PSC 833 combined with weekly intravenous etoposide in children with relapsed or refractory solid tumours.

artículo científico publicado en 2007

Drug discovery in paediatric oncology: roadblocks to progress

artículo científico publicado en 2014

Early advice on managing children with cancer during the COVID-19 pandemic and a call for sharing experiences

scientific article published on 02 April 2020

Embryonal precursors of Wilms tumor

artículo científico publicado en 2019

Equivalent expression of paternally and maternally inherited WT1 alleles in normal fetal tissue and Wilms' tumours

artículo científico publicado el 1 de abril de 1992

European Survey on Standards of Care in paediatric oncology centres

artículo científico publicado en 2016

Evaluation of boost irradiation in patients with intermediate-risk stage III Wilms tumour with positive lymph nodes only: Results from the SIOP-WT-2001 Registry

artículo científico publicado en 2018

Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12–q21

artículo científico publicado en 1996

Evidence-based data and rare cancers: The need for a new methodological approach in research and investigation.

artículo científico publicado en 2018

Follow-up surveillance of Wilm's tumour - Authors' reply

artículo científico publicado en 2018

Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma.

artículo científico publicado en 2010

Gain of 1q is a marker of poor prognosis in Wilms' tumors

artículo científico publicado en 2013

Geographical comparison of cancer survival in European children (1988–1997): Report from the Automated Childhood Cancer Information System project

artículo científico publicado en 2006

Hereditary leiomyomatosis and renal cell carcinoma: very early diagnosis of renal cancer in a paediatric patient

artículo científico publicado en 2010

Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group

artículo científico publicado en 2006

Incidence and outcomes of patients with late recurrence of Wilms' tumor

artículo científico publicado en 2013

Incidence of and survival from Wilms' tumour in adults in Europe: data from the EUROCARE study.

artículo científico publicado en 2006

Incidence of childhood renal tumours: An international population-based study

artículo científico publicado en 2020

Insights into the experiences of patients with cancer in London: framework analysis of free-text data from the National Cancer Patient Experience Survey 2012/2013 from the two London Integrated Cancer Systems

artículo científico publicado en 2015

Irinotecan for relapsed Wilms tumor in pediatric patients: SIOP experience and review of the literature-A report from the SIOP Renal Tumor Study Group

artículo científico publicado en 2017

Is Wilms tumor a candidate neoplasia for treatment with WNT/β-catenin pathway modulators?--A report from the renal tumors biology-driven drug development workshop

artículo científico publicado en 2013

Malignant Origin of the Stromal Component of Wilms' Tumor ⬇️

artículo científico publicado el 6 de agosto de 1997

Medulloblastoma, acute myelocytic leukemia and colonic carcinomas in a child with biallelic MSH6 mutations

artículo científico publicado en 2007

Mesoblastic nephroma: a report of the United Kingdom Children's Cancer and Leukaemia Group (CCLG).

scientific article published on 16 January 2011

MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas

artículo científico publicado en 2010

Molecular profiling reveals frequent gain of MYCN and anaplasia-specific loss of 4q and 14q in wilms tumor

article

Multidrug resistance modulation in rhabdomyosarcoma and neuroblastoma cell lines ⬇️

artículo científico publicado el 1 de mayo de 1998

Mutational Analysis of the Wilms' Tumor (WT1) Gene

artículo científico publicado el 1 de enero de 1996

Nascent pre-rRNA overexpression correlates with an adverse prognosis in alveolar rhabdomyosarcoma

scientific article published on 01 September 2006

Outcome after pulmonary radiotherapy in Wilms' tumor patients with pulmonary metastases at diagnosis: a UK Children's Cancer Study Group, Wilms' Tumour Working Group Study

scientific article published on 05 November 2007

Outcomes of non-anaplastic stage III and 'inoperable' Wilms tumour treated in the UKW3 trial

scientific article published on 15 December 2018

PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification.

artículo científico publicado en 2012

Pediatric and young adult renal cell carcinoma

scientific article published on 01 September 2020

Pharmacotherapeutic Management of Wilms Tumor: An Update

artículo científico publicado en 2019

Population survival from childhood cancer in Britain during 1978-2005 by eras of entry to clinical trials.

artículo científico publicado en 2012

Publisher Correction: The UMBRELLA SIOP-RTSG 2016 Wilms tumour pathology and molecular biology protocol

artículo científico publicado en 2019

Regarding "expression of the Wilms' tumor gene (WT1) in normal hemopoiesis" by P.N. Baird and P.J. Simmons, Experimental Hematology 25:312-320 (1997)

artículo científico publicado el 1 de diciembre de 1997

Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol database

artículo científico publicado en 2018

Response to the letter to the editor: 1q gain is a frequent finding in preoperatively treated Wilms tumors, but of limited prognostic value for risk satisfaction in the SIOP2009/Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH) trial

artículo científico publicado en 2015

Risk factors for local recurrence in Wilms tumour and the potential influence of biopsy - the United Kingdom experience

artículo científico publicado en 2014

Role of CD56 in Normal Kidney Development and Wilms Tumorigenesis

artículo científico publicado en 2016

Science and health for all children with cancer

artículo científico publicado en 2019

Seeking consent to tissue banking: a survey of health professionals in childhood cancer

article

Somatic TP53 Mutations Are Detectable in Circulating Tumor DNA from Children with Anaplastic Wilms Tumors

artículo científico publicado en 2018

Stage at diagnosis for childhood solid cancers in Australia: A population-based study

scientific article published on 01 March 2019

Subtype-specific FBXW7 mutation and MYCN copy number gain in Wilms' tumor.

artículo científico publicado en 2010

Surveillance for Wilms tumour in at-risk children: pragmatic recommendations for best practice

artículo científico publicado en 2006

T-cell responses in osteosarcoma patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55

artículo científico publicado en 2008

The COVID-19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI, and St Jude Global

scientific article published on 13 May 2020

The Wilms Tumour GeneWT1in Leukaemia ⬇️

artículo científico publicado el 1 de octubre de 1997

The diagnostic accuracy and clinical utility of pediatric renal tumor biopsy: Report of the UK experience in the SIOP UK WT 2001 trial.

artículo científico publicado en 2019

The familial Wilms' tumour susceptibility gene, FWT1, may not be a tumour suppressor gene

article

The genetic changes of Wilms tumour

scientific article published on 01 April 2019

Towards reducing inequalities: European Standards of Care for Children with Cancer

artículo científico publicado en 2013

Toxicity and outcome of children and adolescents participating in phase I/II trials of novel anticancer drugs: the Royal Marsden experience.

artículo científico publicado en 2014

Treating burkitt's lymphoma in Malawi, Cameroon, and Ghana.

artículo científico publicado en 2008

Treatment and outcome of Wilms' tumour patients: an analysis of all cases registered in the UKW3 trial.

artículo científico publicado en 2012

Treatment and outcome of patients with relapsed clear cell sarcoma of the kidney: a combined SIOP and AIEOP study

artículo científico publicado en 2014

Treatment of relapsed Wilms tumors: lessons learned.

artículo científico publicado en 2009

UK childhood cancer survival falling behind rest of EU?

artículo científico publicado en 2007

WARNING: G-401 and SK-NEP-1 cell lines are not Wilms tumor cell lines

scientific article published on 29 March 2019

Wilms' tumor (WT1) gene mutations occur mainly in acute myeloid leukemia and may confer drug resistance ⬇️

artículo científico publicado el 15 de abril de 1998

Wilms' tumor: biology, diagnosis and treatment

artículo científico publicado en 2014

Lista de obras de Kathryn Pritchard-Jones

A genome-wide association study identifies susceptibility loci for Wilms tumor

A prospective study of admissions for febrile neutropenia in secondary paediatric units in South East England.

Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma

An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity

Analysis by array CGH of genomic changes associated with the progression or relapse of Wilms' tumour

Array CGH profiling of favourable histology Wilms tumours reveals novel gains and losses associated with relapse

Cancer in children and adolescents in Europe: developments over 20 years and future challenges.

Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis

Centralising specialist cancer surgery services in England: survey of factors that matter to patients and carers and health professionals.

Childhood cancer incidence and survival in Japan and England: A population-based study (1993-2010).

Children with cancer: driving the global agenda ⬇️

Commissioning: aiming for a gold standard of care

Comparative genomic hybridization and BUB1B mutation analyses in childhood cancers associated with mosaic variegated aneuploidy syndrome

Complex patterns of chromosome 9 alterations including the p16INK4a locus in Wilms tumours

Confirmation of FWT1 as a Wilms' tumour susceptibility gene and phenotypic characteristics of Wilms' tumour attributable to FWT1

Congenital mesoblastic nephroma 50 years after its recognition: A narrative review

Consent to tissue banking for research: qualitative study and recommendations ⬇️

Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumor.

Constitutional translocation breakpoint mapping by genome-wide paired-end sequencing identifies HACE1 as a putative Wilms tumour susceptibility gene

DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome

Delineation of a 1Mb breakpoint region at 1p13 in Wilms tumors by fine-tiling oligonucleotide array CGH

Differential splicing of exon 5 of the Wilms tumour (WT1) gene ⬇️

Discrete-choice experiment to analyse preferences for centralizing specialist cancer surgery services.

Dose finding study of oral PSC 833 combined with weekly intravenous etoposide in children with relapsed or refractory solid tumours.

Drug discovery in paediatric oncology: roadblocks to progress

Early advice on managing children with cancer during the COVID-19 pandemic and a call for sharing experiences

Embryonal precursors of Wilms tumor

Equivalent expression of paternally and maternally inherited WT1 alleles in normal fetal tissue and Wilms' tumours

European Survey on Standards of Care in paediatric oncology centres

Evaluation of boost irradiation in patients with intermediate-risk stage III Wilms tumour with positive lymph nodes only: Results from the SIOP-WT-2001 Registry

Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12–q21

Evidence-based data and rare cancers: The need for a new methodological approach in research and investigation.

Follow-up surveillance of Wilm's tumour - Authors' reply

Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma.

Gain of 1q is a marker of poor prognosis in Wilms' tumors

Geographical comparison of cancer survival in European children (1988–1997): Report from the Automated Childhood Cancer Information System project

Hereditary leiomyomatosis and renal cell carcinoma: very early diagnosis of renal cancer in a paediatric patient

Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group

Incidence and outcomes of patients with late recurrence of Wilms' tumor

Incidence of and survival from Wilms' tumour in adults in Europe: data from the EUROCARE study.

Incidence of childhood renal tumours: An international population-based study

Insights into the experiences of patients with cancer in London: framework analysis of free-text data from the National Cancer Patient Experience Survey 2012/2013 from the two London Integrated Cancer Systems

Irinotecan for relapsed Wilms tumor in pediatric patients: SIOP experience and review of the literature-A report from the SIOP Renal Tumor Study Group

Is Wilms tumor a candidate neoplasia for treatment with WNT/β-catenin pathway modulators?--A report from the renal tumors biology-driven drug development workshop

Malignant Origin of the Stromal Component of Wilms' Tumor ⬇️

Medulloblastoma, acute myelocytic leukemia and colonic carcinomas in a child with biallelic MSH6 mutations

Mesoblastic nephroma: a report of the United Kingdom Children's Cancer and Leukaemia Group (CCLG).

MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas

Molecular profiling reveals frequent gain of MYCN and anaplasia-specific loss of 4q and 14q in wilms tumor

Multidrug resistance modulation in rhabdomyosarcoma and neuroblastoma cell lines ⬇️

Mutational Analysis of the Wilms' Tumor (WT1) Gene

Nascent pre-rRNA overexpression correlates with an adverse prognosis in alveolar rhabdomyosarcoma

Outcome after pulmonary radiotherapy in Wilms' tumor patients with pulmonary metastases at diagnosis: a UK Children's Cancer Study Group, Wilms' Tumour Working Group Study

Outcomes of non-anaplastic stage III and 'inoperable' Wilms tumour treated in the UKW3 trial

PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification.

Pediatric and young adult renal cell carcinoma

Pharmacotherapeutic Management of Wilms Tumor: An Update

Population survival from childhood cancer in Britain during 1978-2005 by eras of entry to clinical trials.

Publisher Correction: The UMBRELLA SIOP-RTSG 2016 Wilms tumour pathology and molecular biology protocol

Regarding "expression of the Wilms' tumor gene (WT1) in normal hemopoiesis" by P.N. Baird and P.J. Simmons, Experimental Hematology 25:312-320 (1997)

Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol database

Response to the letter to the editor: 1q gain is a frequent finding in preoperatively treated Wilms tumors, but of limited prognostic value for risk satisfaction in the SIOP2009/Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH) trial

Risk factors for local recurrence in Wilms tumour and the potential influence of biopsy - the United Kingdom experience

Role of CD56 in Normal Kidney Development and Wilms Tumorigenesis

Science and health for all children with cancer

Seeking consent to tissue banking: a survey of health professionals in childhood cancer

Somatic TP53 Mutations Are Detectable in Circulating Tumor DNA from Children with Anaplastic Wilms Tumors

Stage at diagnosis for childhood solid cancers in Australia: A population-based study

Subtype-specific FBXW7 mutation and MYCN copy number gain in Wilms' tumor.

Surveillance for Wilms tumour in at-risk children: pragmatic recommendations for best practice

T-cell responses in osteosarcoma patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55

The COVID-19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI, and St Jude Global

The Wilms Tumour GeneWT1in Leukaemia ⬇️

The diagnostic accuracy and clinical utility of pediatric renal tumor biopsy: Report of the UK experience in the SIOP UK WT 2001 trial.

The familial Wilms' tumour susceptibility gene, FWT1, may not be a tumour suppressor gene

The genetic changes of Wilms tumour

Towards reducing inequalities: European Standards of Care for Children with Cancer

Toxicity and outcome of children and adolescents participating in phase I/II trials of novel anticancer drugs: the Royal Marsden experience.

Treating burkitt's lymphoma in Malawi, Cameroon, and Ghana.